Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Prosidion, Probiodrug metabolic deal

OSI (OSIP) subsidiary Prosidion (Oxford, U.K.) acquired from Probiodrug (Halle, Germany) a dipeptidyl peptidase IV (DPP

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE